When Martin Kampmann, PhD, set out to explore the workings of the human brain, he was captivated by its greatest mystery: how a network of cells could produce something as intangible as thoughts, ...
In a groundbreaking fusion of artificial intelligence and gene editing, researchers are leveraging machine learning to enhance CRISPR technology’s precision and efficiency. This integration is opening ...
ZME Science on MSN
Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
In January 2020, CRISPR startup Sherlock Biosciences was in the middle of working on CRISPR-based tests that could deliver lab quality testing at home for common illnesses like flu or sexually ...
Share on Pinterest Researchers are hoping the CRISPR gene-splicing technology can be used to treat dementia and ALS. Getty Images Researchers are looking at the CRISPR gene-splicing technology to see ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
The concept of CRISPR gene-editing is still quite young. Although the discovery of CRISPRs themselves—repeating DNA sequences present in single-celled organisms, such as bacteria—can be traced back to ...
CRISPR excites ambition. Just consider a few CRISPR applications: gene drives (showing promise as a way to prevent malaria); ex vivo and in vivo gene therapies (entering clinical trials); and ...
Although existing CRISPR-Cas-based imaging methods can target endogenous genomic sequences, their applications are limited by system complexity and sensitivity, particularly when imaging ...
The Situation: Recent developments in the patent landscape of Clustered Regularly Interspaced Short Palindromic Repeats ("CRISPR") gene-editing technology are increasingly impacting global food ...
May 12 (Reuters) - The University of California and the University of Vienna on Monday convinced a U.S. appeals court to revive their bid for patent rights to groundbreaking CRISPR gene-editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback